Literature DB >> 12673431

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

David Moher1, Kenneth F Schulz, Douglas G Altman.   

Abstract

To comprehend the results of a randomised controlled trial (RCT), readers must understand its design, conduct, analysis, and interpretation. That goal can be achieved only through total transparency from authors. Despite several decades of educational efforts, the reporting of RCTs needs improvement. Investigators and editors developed the original CONSORT (Consolidated Standards of Reporting Trials) statement to help authors improve reporting by use of a checklist and flow diagram. The revised CONSORT statement presented here incorporates new evidence and addresses some criticisms of the original statement. The checklist items pertain to the content of the Title, Abstract, Introduction, Methods, Results, and Discussion. The revised checklist includes 22 items selected because empirical evidence indicates that not reporting this information is associated with biased estimates of treatment effect, or because the information is essential to judge the reliability or relevance of the findings. We intended the flow diagram to depict the passage of participants through an RCT. The revised flow diagram depicts information from four stages of a trial (enrollment, intervention allocation, follow- up, and analysis). The diagram explicitly shows the number of participants, for each intervention group, included in the primary data analysis. Inclusion of these numbers allows the reader to judge whether the authors have done an intention- to-treat analysis. In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.

Entities:  

Mesh:

Year:  2003        PMID: 12673431     DOI: 10.1007/s00784-002-0188-x

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  24 in total

Review 1.  What is meant by intention to treat analysis? Survey of published randomised controlled trials.

Authors:  S Hollis; F Campbell
Journal:  BMJ       Date:  1999-09-11

2.  Intention to treat analysis is related to methodological quality.

Authors:  M Ruiz-Canela; M A Martínez-González; J de Irala-Estévez
Journal:  BMJ       Date:  2000-04-08

3.  The quality of reporting in published cost-utility analyses, 1976-1997.

Authors:  P J Neumann; P W Stone; R H Chapman; E A Sandberg; C M Bell
Journal:  Ann Intern Med       Date:  2000-06-20       Impact factor: 25.391

4.  Analysis of clinical trials by treatment actually received: is it really an option?

Authors:  Y J Lee; J H Ellenberg; D G Hirtz; K B Nelson
Journal:  Stat Med       Date:  1991-10       Impact factor: 2.373

5.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

Review 6.  Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.

Authors:  M Hotopf; G Lewis; C Normand
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

7.  The quest for unbiased research: randomized clinical trials and the CONSORT reporting guidelines.

Authors:  K F Schulz
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

Review 8.  Size and quality of randomised controlled trials in head injury: review of published studies.

Authors:  K Dickinson; F Bunn; R Wentz; P Edwards; I Roberts
Journal:  BMJ       Date:  2000-05-13

9.  The scandal of poor medical research.

Authors:  D G Altman
Journal:  BMJ       Date:  1994-01-29

10.  Current Controlled Trials: an opportunity to help improve the quality of clinical research.

Authors:  Iain Chalmers
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000
View more
  42 in total

1.  Marginal adaptation of a low-shrinkage silorane-based composite: 1-year randomized clinical trial.

Authors:  Malene Schmidt; Lise-Lotte Kirkevang; Preben Hørsted-Bindslev; Sven Poulsen
Journal:  Clin Oral Investig       Date:  2010-07-20       Impact factor: 3.573

2.  Five-year evaluation of a low-shrinkage Silorane resin composite material: a randomized clinical trial.

Authors:  Malene Schmidt; Irene Dige; Lise-Lotte Kirkevang; Michael Vaeth; Preben Hørsted-Bindslev
Journal:  Clin Oral Investig       Date:  2014-04-01       Impact factor: 3.573

Review 3.  Methodological aspects of outcomes research.

Authors:  Rudi Hiebert; Margareta Nordin
Journal:  Eur Spine J       Date:  2005-11-30       Impact factor: 3.134

4.  Reporting of systematic reviews of micronutrients and health: a critical appraisal.

Authors:  Mei Chung; Ethan M Balk; Stanley Ip; Gowri Raman; Winifred W Yu; Thomas A Trikalinos; Alice H Lichtenstein; Elizabeth A Yetley; Joseph Lau
Journal:  Am J Clin Nutr       Date:  2009-02-25       Impact factor: 7.045

Review 5.  Randomized controlled trials in endourology: a quality assessment.

Authors:  Jung Ki Jo; Riccardo Autorino; Jae Hoon Chung; Kyu Shik Kim; Jeong Woo Lee; Eun Jung Baek; Seung Wook Lee
Journal:  J Endourol       Date:  2013-07-26       Impact factor: 2.942

6.  Application of the CONSORT statement to randomized controlled trials comparing endoscopic and open carpal tunnel release.

Authors:  Achilleas Thoma; Roderick T Chew; Sheila Sprague; Karen Veltri
Journal:  Can J Plast Surg       Date:  2006

Review 7.  Effect of nonsurgical periodontal treatment on glycosylated hemoglobin in diabetic patients: a systematic review.

Authors:  Elisabet Mauri-Obradors; Enric Jané-Salas; Maria del Mar Sabater-Recolons; Miguel Vinas; José López-López
Journal:  Odontology       Date:  2014-07-26       Impact factor: 2.634

8.  Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial.

Authors:  Michael Berk; Robyn L Woods; Mark R Nelson; Raj C Shah; Christopher M Reid; Elsdon Storey; Sharyn Fitzgerald; Jessica E Lockery; Rory Wolfe; Mohammadreza Mohebbi; Seetal Dodd; Anne M Murray; Nigel Stocks; Paul B Fitzgerald; Catherine Mazza; Bruno Agustini; John J McNeil
Journal:  JAMA Psychiatry       Date:  2020-10-01       Impact factor: 21.596

9.  Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.

Authors:  Elkanah Omenge Orang'o; Tao Liu; Astrid Christoffersen-Deb; Peter Itsura; John Oguda; Sierra Washington; David Chumba; Latha Pisharodi; Susan Cu-Uvin; Anne F Rositch
Journal:  AIDS       Date:  2017-01-14       Impact factor: 4.177

10.  A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors.

Authors:  Y Yazici; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-07-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.